Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
NCT02090530 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-04-08
Summary
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Conditions
Interventions
- OTHER
-
Biospecimen collection
Specimens to be collected include a fresh tumor biopsy, previously obtained tumor specimens or blocks (if available), whole blood, serum, plasma and buccal smear.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Ohio State University Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Sameek Roychowdhury, MD, PhD · Ohio State University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-04
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Collection of Blood Specimens for Circulating Tumor Cell Analysis
NCT01943500 ·Status: COMPLETED
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
NCT02215928 ·Status: RECRUITING
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies
NCT01802905 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
PREcision Medicine in Cancer in Odense, Denmark
NCT05385081 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
NCT06630429 ·Status: ACTIVE_NOT_RECRUITING
-
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 ·Status: RECRUITING
-
Taiwan Cancer Moonshot Project
NCT05248763 ·Status: RECRUITING
-
Medical Data Collection in the Formation of Precision Oncology Registry
NCT03874065 ·Status: TERMINATED
-
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056 ·Status: WITHDRAWN
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Urine Omics Predicting IO Therapy Responses in mRCC Patients
NCT04712305 ·Status: RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
NCT02141152 ·Status: COMPLETED
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT01109394 ·Status: RECRUITING
-
CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer
NCT05652569 ·Status: RECRUITING
-
Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer
NCT05032092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA